The vast majority of the patients who take statins don’t ever have to worry about the side effect of muscle symptoms. Even among those who do experience muscle damage, with […]
LEAP Rounds – Holiday 2021
News
LEAP Rounds – Fall 2021
A prevalent belief among rheumatologists has been that an accurate diagnosis of Sjögren’s is not essential because of the lack of disease-modifying therapies. But a correct diagnosis is very important […]
LEAP – Winter 2021: Flashes of Insight
This is an unusual time, and this year’s LEAP reflects it well: we start with Covid-19’s very sickest patients, and a Hopkins-wide team’s groundbreaking efforts to illuminate an unusual response in their immune system.
We end with a remarkable patient with a rare autoimmune disease: the legendary musician, Peter Frampton, who is not only raising awareness and research funding, but changing medical advice about how to preserve muscle function.
Impact of the COVID-19 pandemic on patients with ANCA vasculitis
The COVID-19 pandemic has caused significant disruptions to ANCA vasculitis patient care, but these patients are not at higher risk for COVID-19 than the general population, despite receiving immunosuppressive therapy.
Hot spots in Topo protein drive shared autoimmune responses in scleroderma patients
Researchers at Johns Hopkins identified “hot spots” in the Topo protein that are targeted by the immune system in scleroderma patients with different genetic backgrounds, which may help us understand why the immune system attacks healthy tissues in this autoimmune disease.
LEAP Rounds – Spring 2020
Corticosteroids (prednisone) are the mainstay of therapy for systemic lupus erythematosus (SLE). Prednisone works: it has anti-inflammatory and immunosuppressive actions in SLE. This is why doctors who treat lupus patients […]
